Gautam Nitesh, Saluja Prachi, Malkawi Abdallah, Rabbat Mark G, Al-Mallah Mouaz H, Pontone Gianluca, Zhang Yiye, Lee Benjamin C, Al'Aref Subhi J
Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Department of Medicine, Division of Cardiology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Healthcare (Basel). 2022 Jan 26;10(2):232. doi: 10.3390/healthcare10020232.
Cardiovascular diseases (CVDs) carry significant morbidity and mortality and are associated with substantial economic burden on healthcare systems around the world. Coronary artery disease, as one disease entity under the CVDs umbrella, had a prevalence of 7.2% among adults in the United States and incurred a financial burden of 360 billion US dollars in the years 2016-2017. The introduction of artificial intelligence (AI) and machine learning over the last two decades has unlocked new dimensions in the field of cardiovascular medicine. From automatic interpretations of heart rhythm disorders via smartwatches, to assisting in complex decision-making, AI has quickly expanded its realms in medicine and has demonstrated itself as a promising tool in helping clinicians guide treatment decisions. Understanding complex genetic interactions and developing clinical risk prediction models, advanced cardiac imaging, and improving mortality outcomes are just a few areas where AI has been applied in the domain of coronary artery disease. Through this review, we sought to summarize the advances in AI relating to coronary artery disease, current limitations, and future perspectives.
心血管疾病(CVDs)具有很高的发病率和死亡率,并给全球医疗系统带来了巨大的经济负担。冠状动脉疾病作为心血管疾病范畴内的一种疾病实体,在美国成年人中的患病率为7.2%,在2016 - 2017年期间造成了3600亿美元的经济负担。在过去二十年中,人工智能(AI)和机器学习的引入为心血管医学领域开辟了新的维度。从通过智能手表自动解读心律失常,到协助进行复杂的决策,人工智能已迅速在医学领域拓展其版图,并已证明自身是帮助临床医生指导治疗决策的一种有前景的工具。理解复杂的基因相互作用、开发临床风险预测模型、先进的心脏成像以及改善死亡率结果,只是人工智能在冠状动脉疾病领域应用的几个方面。通过本综述,我们试图总结人工智能在冠状动脉疾病方面的进展、当前局限性以及未来展望。